Semaglutide is the active ingredient in Wegovy this medication can aid with weight loss in diabetics and nondiabetics. It is a once-weekly injectable medication, belonging to a class of medications called GLP-1.
Semaglutide works by acting on the hypothalamus in the brain, which regulates our feeling of hunger. It also works by slowing down the motility of the gastrointestinal tract, keeping us feeling full longer.
Many patients begin to lose weight in the first week of taking semaglutide. We start the dose small, and titrate up every 4 weeks. This is done to gently introduce the medication to the body and minimize any possible side effects.
Some people experience mild side effects and those are nausea, vomiting, diarrhea, constipation, fatigue, hypoglycemia, feeling bloated or heartburn.
Those who should not use semaglutide are:
Most insurance companies do not cover Semaglutide for weight loss and so Body Better Weight Loss has worked hard to develop a relationship with a compounding pharmacy to provide this medication at a discount to our patients.
In Ohio Phentermine is approved for short-term use only, usually no more than 12 weeks and can only be continued if there is a documented 5% weight reduction or more weight loss after the 12 weeks.
Tirzepatide is the active ingredient in Zepbound. This medication was developed to help manage type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists. These are hormones that help regulate blood sugar levels and stimulate insulin production.
Tirzepatide works by activating both GLP-1 and GIP receptors. By doing so, it has a dual effect on blood sugar control. It helps lower blood sugar levels by stimulating insulin release from the pancreas when blood sugar is high. Additionally, it slows down the release of glucagon, a hormone that raises blood sugar levels. This combined action helps to keep blood sugar levels within a healthy range